Zobrazeno 41 - 50
of 1 654
pro vyhledávání: ''
Autor:
Pinar Tasar, Nesrin Ugras, Aslı Ceren Macunluoğlu, Omer Yerci, Seçil Hasdemir, Halit Ziya Dündar
Publikováno v:
Tumori Journal. 107:80-85
Background: Pancreatic neuroendocrine neoplasms (NENs) are tumors with histopathologic and prognostic heterogeneity that pose difficulties in establishing standards for diagnosis, classification, and treatment. Among NENs, well-differentiated neuroen
Autor:
Nerina Denaro, Cristina Granetto, Ornella Garrone, Vincenzo Ricci, Paola Vanella, Ida Colantonio, Nicola Crosetto, Anna Maria Vandone, Marcella Occelli, Fiorella Ruatta, Marco Merlano, Carolina Cauchi, Gianna Di Costanzo, Elena Fea
Publikováno v:
Tumori Journal. 106:427-431
Background:The coronavirus disease 2019 (COVID-19) pandemic is posing an unprecedented dilemma to oncologists worldwide, forcing them to decide whether to continue or suspend treatments in order to protect their most vulnerable patients from infectio
Autor:
Lucia Bisceglia, Margherita Tanzarella, Vincenzo Coviello, Enrico Caputo, Anna Melcarne, Emma Cozzi, Fernando Palma, Francesco Cuccaro, Ivan Rashid, Maria Giovanna Burgio Lo Monaco
Publikováno v:
Tumori Journal. 107:39-45
Introduction:This study presents the incidence of gastrointestinal stromal tumors (GISTs) in an Italian region of over 4 million inhabitants monitored for 10 years and is the largest incidence study of this type of cancer conducted so far in Italy.Me
Autor:
Figen Aslan, Ülkü Küçük
Publikováno v:
Ear, Nose & Throat Journal. 99:475-480
Aslan, Figen (Balikesir Author)
Objectives: The pathogenesis and molecular basis of salivary gland tumors (SGT) are not well understood. We investigated the expression of receptor activator of nuclear factor kappa B (RANK) and RANK ligand (RANKL
Objectives: The pathogenesis and molecular basis of salivary gland tumors (SGT) are not well understood. We investigated the expression of receptor activator of nuclear factor kappa B (RANK) and RANK ligand (RANKL
Autor:
Shengji Yu, Xinxin Zhang, Songfeng Xu, Changyou Jing, Libin Xu, Shuguang Zhang, Ting Liu, Zhenguo Zhao
Publikováno v:
The International Journal of Biological Markers. 35:14-22
Background The aim of this study was to evaluate the landscape of gene mutations and the clinical significance of tumor mutation burden (TMB) in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant the
Autor:
Andrea Vingiani, Anna Borelli, Gianfranco Scaperrotta, Catherine Depretto, Francesco Cartia, Claudio Ferranti, Gabriele Presti, Alessandro Liguori
Publikováno v:
Tumori Journal. 106:491-496
Aim: To evaluate the presence of contrast enhancement at the site of calcifications on contrast-enhanced mammography (CEM) and histopathologic results at vacuum-assisted biopsy (VAB), and to examine the association with lesion size and immunohistoche
Autor:
Nathalie Ausias, Patrice Vanelle, Fabrice Barlesi, Roch Giorgi, Marc Montana, Mathieu Peretti, Marie Eve Garcia, François Cavaille
Publikováno v:
Tumori
Tumori, 2021, 107 (1), pp.32-38. ⟨10.1177/0300891620926244⟩
Tumori, Casa Editrice Ambrosiana, 2020, pp.030089162092624. ⟨10.1177/0300891620926244⟩
Tumori, 2021, 107 (1), pp.32-38. ⟨10.1177/0300891620926244⟩
Tumori, Casa Editrice Ambrosiana, 2020, pp.030089162092624. ⟨10.1177/0300891620926244⟩
Background: Pembrolizumab, a humanized immunoglobulin monoclonal antibody directed against the programmed cell death 1 receptor, demonstrated robust efficacy and a manageable safety profile across multiple tumor types in clinical trials. Aim: To inve
Publikováno v:
Tumori Journal. 106:NP79-NP83
Background: Papillary renal cell carcinoma (pRCC) represents the second most common histologic subtype of renal cell carcinoma and comprises 2 subtypes. Prognosis for type 2 is associated with poor clinical outcome. Current guidelines are based on ph
Autor:
Francesco Cellini, Emanuele Rocco Villani, Stefania Manfrida, Giuditta Chiloiro, Maria Antonietta Gambacorta, Andrea Bellieni, Giuseppe Colloca, Luca Boldrini, Vincenzo Valentini
Publikováno v:
Tumori Journal. 107:26-31
Background: Elderly patients are often excluded from advanced treatments owing to clinical complexity or frailty. Magnetic resonance–guided radiotherapy (MRgRT) represents a new frontier of radiotherapy delivery that can play an important role in t
Autor:
Hakan Gurkan, Sinem Yalcintepe, Damla Eker, Hilmi Tozkir, Irfan Cicin, Emine Ikbal Atli, Huseyin Ahmet Tezel, Engin Atli, Selma Demir
Publikováno v:
Tumori Journal. 106:510-517
Background: Recent advances in next-generation sequencing (NGS) technology have enabled multigene testing and changed the diagnostic approach to hereditary gastrointestinal cancer/polyposis syndromes. The aim of this study was to analyze different ca